Guardant Health, Inc. Profile Avatar - Palmy Investing

Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for…
Medical - Diagnostics & Research
US, Redwood City [HQ]

Balance Sheet

8 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2016 2017 2018 2019 2020 2021 2022 2023
Assets
116.00 342.00 587.00 962.00 2,271.00 2,204.00 1,609.00 1,786.00
Current
103.00 242.00 468.00 597.00 1,888.00 1,114.00 1,191.00 1,347.00
Non Current
13.00 100.00 118.00 365.00 383.00 1,090.00 418.00 439.00
Liabilities
36.00 34.00 62.00 114.00 916.00 1,559.00 1,549.00 1,627.00
Current
14.00 19.00 46.00 72.00 66.00 194.00 193.00 205.00
Non Current
22.00 14.00 15.00 41.00 849.00 1,364.00 1,356.00 1,421.00
Equity
79.00 308.00 524.00 847.00 1,355.00 723.00 60.00 158.00
Stockholders' Equity
79.00 308.00 483.00 798.00 1,298.00 645.00 60.00 158.00
Retained Earnings
-107.00 -195.00 -280.00 -352.00 -606.00 -1,007.00 -1,662.00 -2,141.00
Common Stock
- - - - - - - - - - - - - - - -
Preferred Stock
179.00 499.00 - - - - - - - - - - - -
Profit
-46.00 -83.00 -85.00 -67.00 -246.00 -384.00 -654.00 -479.00
Dividends
- - - - -3.00 - - - - - - - - - -
Minority Interest
- - - - 41.00 49.00 57.00 78.00 - - - -
Other Stockholders' Equity
7.00 4.00 764.00 1,150.00 1,902.00 1,657.00 1,742.00 2,304.00
Loss Other Compr. Income
- - - - - - 1.00 2.00 -4.00 -19.00 -3.00
End of GH's Analysis
CIK: 1576280 CUSIP: 40131M109 ISIN: US40131M1099 LEI: - UEI: -
Secondary Listings
GH has no secondary listings inside our databases.